- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03880344
Investigating the Effectiveness of Vibration Therapy on Sarcopenia in Osteoarthritis Knee Patients
Randomized Control Trial Investigating the Effectiveness of Vibration Therapy on Sarcopenia in Osteoarthritis Knee Patients
Study Overview
Status
Intervention / Treatment
Detailed Description
Patients with end stage OA often adopt a sedentary lifestyle causing mobility and functionality decline to avoid joint pain and stiffness. This dysfunctions a series of antioxidant response cascades which eventually leads to muscle atrophy of the knee. Notably, muscle atrophy and weakness (i.e. sarcopenia) often accompanies with OA. However the relationship between these symptoms and OA remains undefined and no strong consensus have been made thus far. Our ongoing longitudinal study on muscle strength and functionality which investigates the prevalence of sarcopenia in end stage OA patient's pre and post operation (Total Knee Replacement) have reflected that 24% with severe knee OA patients also suffered sarcopenia. In addition, these patients also showed a much slower recovery and longer length of stay in hospital after undergoing surgical operation.
The effect of clinical sarcopenia affects our locomotion system in the aging population. Weakness in patients and decline in muscle strength results in significant functional impairment are often seen in the cohort, leading to fragility, falls, fractures and disability.
Many authors have tried to explain the pathophysiology of sarcopenia in an attempt to link the disorder to a molecular or biochemical level in numerous literature. Satellite cells (a myogenic stem cell), Insulin like growth factor 1 (IGF-1) (an important mediator of muscle growth and regeneration affecting muscle function) and fast twitch muscle fibres are three major molecular composites that have been widely studied. Evidence have suggested the close relationship between them and muscle atrophy and weakness. However, these studies have either shown the results from an animal standpoint or they lack specificity and further research is necessary to confirm their role in patients suffering from sarcopenia.
Attempts have also been made to discover the most effective intervention to treat or even eliminate the chances of sarcopenia. Among these studies resistance exercises have been documented the most.
Evidence showed that progressive resistance and aerobic exercises are most beneficial for the prevention and treatment of sarcopenia. Resistant training that such as lifting weights, strength resistance bands, resistance machines has shown to improve protein synthesis in skeletal muscle cells leading to better muscle strength and mass, leading to muscle hypertrophy and promotes muscle power. Our previous knowledge transfer study on developing an aerobic exercise (i.e. Tai Chi Exercise) for end stage OA patients also showed similar positive effects in subjects, decreasing their pain and stiffness symptoms and limitations in physical activity. Though resistance exercise showed promising effects, are safe and strongly advised interventions based on documented and our previous study, the elderly populations often accompanies with other physical symptoms (such as back pain) and diminished fine motor skills that may limit their range of movement in these exercise regimes. In addition, resistive exercises are extremely technical and is essential to execute with proper form to avoid further injury; hence these exercises are unable to perform safely alone at home, making the intervention less autonomous.
Vibration therapy is a noninvasive biophysical modality and has been demonstrated in a number of studies showing multiple positive effects in terms of postural control, balancing ability, circulation and most importantly muscle strength. Two of our previous studies investigated the long term effects on muscle performance and bone quality in using low-magnitude high frequency vibration. Though the results showed that the treatment is an effective method in fall prevention by improving on both frontiers, these two studies' main subject focuses were on the elderly population as a whole. A study pivoting on subjects with co-existing diagnosis of sarcopenia and OA is crucial to investigate the effectiveness of this therapy method. Limited studies have shown positive effects of vibration therapy on osteoarthritis, however, these studies were limited to a single gender (i.e. females) or contained subject recruitment bias or assessment period of less than 6 months. A randomized control trial with a longer assessment period is essential to investigate the true effects of vibration therapy on knee OA patients.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Hong Kong, Hong Kong
- Recruiting
- Department of Orthopaedics & Traumatology
-
Contact:
- Ki Wai Ho, MBChB, MSc, MRCSEd, FRCSEd
- Phone Number: (852) 3505 2715
- Email: kevinho@cuhk.edu.hk
-
Principal Investigator:
- Ki Wai Ho, MBChB, MSc, MRCSEd, FRCSEd
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Male and female patients aged over 45 with end stage knee OA
- Patient has been scheduled for TKR
- Able to comply with the assessments and has given oral and written consent
Exclusion Criteria:
- Patients with connective tissue disorders or myositis condition
- Previous cases of alcoholism or drug abuse
- Pregnancy or breast feeding
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Vibration Therapy + Normal Out-Patient Physiotherapy
Patients' randomized to this group will receive vibration therapy as a pre-operative rehabilitation programme 3 times a week for 3 months.
Regular out-patient department physiotherapy will also be given.
They will be assessed 6 weeks and 6 months post operatively.
|
Vibration therapy as a pre-operative rehabilitation programme 3 times a week for 3 months + Normal Regular out-patient department physiotherapy
Physiotherapy as post-operative rehabilitation programme for 6 months.
|
Active Comparator: Normal Out-Patient Department Physiotherapy
Patients randomized to this group will receive regular out-patient department physiotherapy postoperatively for 6 months.
They will be assessed 6 weeks and 6 months post operatively.
|
Physiotherapy as post-operative rehabilitation programme for 6 months.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Knee Flexion/Extension Strength
Time Frame: Baseline Assessment
|
Muscle strength on the quadriceps is measured by instructing the patient to perform an active knee flexion/extension movement in a sitting position with both feet free from ground, and the hip and knee joint flexed at 90%.
The optimal isometric force of the knee flexion/extension movement are measured by the dynamometer attached at the malleoli level with a strap.
The measurements (0 to 30 cm) will be taken at maximum force for three times.
|
Baseline Assessment
|
Knee Flexion/Extension Strength
Time Frame: Pre-Operative Assessment
|
Muscle strength on the quadriceps is measured by instructing the patient to perform an active knee flexion/extension movement in a sitting position with both feet free from ground, and the hip and knee joint flexed at 90%.
The optimal isometric force of the knee flexion/extension movement are measured by the dynamometer attached at the malleoli level with a strap.
The measurements (0 to 30 cm) will be taken at maximum force for three times.
|
Pre-Operative Assessment
|
Knee Flexion/Extension Strength
Time Frame: Post-Operative 6 weeks
|
Muscle strength on the quadriceps is measured by instructing the patient to perform an active knee flexion/extension movement in a sitting position with both feet free from ground, and the hip and knee joint flexed at 90%.
The optimal isometric force of the knee flexion/extension movement are measured by the dynamometer attached at the malleoli level with a strap.
The measurements (0 to 30 cm) will be taken at maximum force for three times.
|
Post-Operative 6 weeks
|
Knee Flexion/Extension Strength
Time Frame: Post-Operative 6 months
|
Muscle strength on the quadriceps is measured by instructing the patient to perform an active knee flexion/extension movement in a sitting position with both feet free from ground, and the hip and knee joint flexed at 90%.
The optimal isometric force of the knee flexion/extension movement are measured by the dynamometer attached at the malleoli level with a strap.
The measurements (0 to 30 cm) will be taken at maximum force for three times.
|
Post-Operative 6 months
|
Knee Flexion/Extension Strength
Time Frame: Post-Operative 12 months
|
Muscle strength on the quadriceps is measured by instructing the patient to perform an active knee flexion/extension movement in a sitting position with both feet free from ground, and the hip and knee joint flexed at 90%.
The optimal isometric force of the knee flexion/extension movement are measured by the dynamometer attached at the malleoli level with a strap.
The measurements (0 to 30 cm) will be taken at maximum force for three times.
|
Post-Operative 12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Whole body lean muscle mass
Time Frame: Baseline Assessment
|
DXA measurement scan
|
Baseline Assessment
|
Whole body lean muscle mass
Time Frame: Pre-Operative Assessment
|
DXA measurement scan
|
Pre-Operative Assessment
|
Whole body lean muscle mass
Time Frame: Post-Operative 6 months
|
DXA measurement scan
|
Post-Operative 6 months
|
Muscle Biopsy
Time Frame: Intra-Operatively
|
Types of muscle fibers and satellite cells as Assessed by Muscle Biopsy Assessment
|
Intra-Operatively
|
Knee Functions measure by the Knee Society Score
Time Frame: Baseline Assessment
|
Physician will assess on the Visual Analog Scale in pain score (None to Severe), Flexion Contracture (None to >20°), Extension lag (None to 20°), Total Range of Flexion (0-5° to 121-125°), Alignment (0° to Over 15°), Antero-posterior stability (<5mm to 10+mm), Mediolateral stability (<5° to 15°).
Patients will record individuals' satisfaction, functional activities, and expectations.
|
Baseline Assessment
|
Knee Functions measure by the Knee Society Score
Time Frame: Pre-Operative Assessment
|
Physician will assess on the Visual Analog Scale in pain score (None to Severe), Flexion Contracture (None to >20°), Extension lag (None to 20°), Total Range of Flexion (0-5° to 121-125°), Alignment (0° to Over 15°), Antero-posterior stability (<5mm to 10+mm), Mediolateral stability (<5° to 15°).
Patients will record individuals' satisfaction, functional activities, and expectations.
|
Pre-Operative Assessment
|
Knee Functions measure by the Knee Society Score
Time Frame: Post-Operative 6 weeks
|
Physician will assess on the Visual Analog Scale in pain score (None to Severe), Flexion Contracture (None to >20°), Extension lag (None to 20°), Total Range of Flexion (0-5° to 121-125°), Alignment (0° to Over 15°), Antero-posterior stability (<5mm to 10+mm), Mediolateral stability (<5° to 15°).
Patients will record individuals' satisfaction, functional activities, and expectations.
|
Post-Operative 6 weeks
|
Knee Functions measure by the Knee Society Score
Time Frame: Post-Operative 6 months
|
Physician will assess on the Visual Analog Scale in pain score (None to Severe), Flexion Contracture (None to >20°), Extension lag (None to 20°), Total Range of Flexion (0-5° to 121-125°), Alignment (0° to Over 15°), Antero-posterior stability (<5mm to 10+mm), Mediolateral stability (<5° to 15°).
Patients will record individuals' satisfaction, functional activities, and expectations.
|
Post-Operative 6 months
|
Knee Functions measure by the Knee Society Score
Time Frame: Post-Operative 12 months
|
Physician will assess on the Visual Analog Scale in pain score (None to Severe), Flexion Contracture (None to >20°), Extension lag (None to 20°), Total Range of Flexion (0-5° to 121-125°), Alignment (0° to Over 15°), Antero-posterior stability (<5mm to 10+mm), Mediolateral stability (<5° to 15°).
Patients will record individuals' satisfaction, functional activities, and expectations.
|
Post-Operative 12 months
|
Knee Function measures by 6 meter Timed Walking Gait Test
Time Frame: Baseline Assessment
|
The 10 meter timed walking test is a well-established and documented test for assessment for gait speed in patients.
However, due to space limitations and the exhaustive nature of the test for patients with OA, the 6 meter test has been documented to be a valid and reliable substitute.
Patients will be asked to walk a straight line of 6 meters where the time taken to complete the distance will be measured.
(<7.5 seconds is normal).
|
Baseline Assessment
|
Knee Function measures by 6 meter Timed Walking Gait Test
Time Frame: Pre-Operative Assessment
|
The 10 meter timed walking test is a well-established and documented test for assessment for gait speed in patients.
However, due to space limitations and the exhaustive nature of the test for patients with OA, the 6 meter test has been documented to be a valid and reliable substitute.
Patients will be asked to walk a straight line of 6 meters where the time taken to complete the distance will be measured.
(<7.5 seconds is normal).
|
Pre-Operative Assessment
|
Knee Function measures by 6 meter Timed Walking Gait Test
Time Frame: Post-Operative 6 weeks
|
The 10 meter timed walking test is a well-established and documented test for assessment for gait speed in patients.
However, due to space limitations and the exhaustive nature of the test for patients with OA, the 6 meter test has been documented to be a valid and reliable substitute.
Patients will be asked to walk a straight line of 6 meters where the time taken to complete the distance will be measured.
(<7.5 seconds is normal).
|
Post-Operative 6 weeks
|
Knee Function measures by 6 meter Timed Walking Gait Test
Time Frame: Post-Operative 6 months
|
The 10 meter timed walking test is a well-established and documented test for assessment for gait speed in patients.
However, due to space limitations and the exhaustive nature of the test for patients with OA, the 6 meter test has been documented to be a valid and reliable substitute.
Patients will be asked to walk a straight line of 6 meters where the time taken to complete the distance will be measured.
(<7.5 seconds is normal).
|
Post-Operative 6 months
|
SF-12
Time Frame: Baseline Assessment
|
The 36-Item Short Form Health Survey (SF-12) will be used to measure the health related Quality of Life.
The SF-12 has twelve questions ; the scores are weighted sums of the questions in each section.
Scores range from 0 - 60. Lower scores = more disability, higher scores = less disability.
|
Baseline Assessment
|
SF-12
Time Frame: Pre-Operative Assessment
|
The 36-Item Short Form Health Survey (SF-12) will be used to measure the health related Quality of Life.
The SF-12 has twelve questions ; the scores are weighted sums of the questions in each section.
Scores range from 0 - 60. Lower scores = more disability, higher scores = less disability.
|
Pre-Operative Assessment
|
SF-12
Time Frame: Post-Operative 6 weeks
|
The 36-Item Short Form Health Survey (SF-12) will be used to measure the health related Quality of Life.
The SF-12 has twelve questions ; the scores are weighted sums of the questions in each section.
Scores range from 0 - 60. Lower scores = more disability, higher scores = less disability.
|
Post-Operative 6 weeks
|
SF-12
Time Frame: Post-Operative 6 months
|
The 36-Item Short Form Health Survey (SF-12) will be used to measure the health related Quality of Life.
The SF-12 has twelve questions ; the scores are weighted sums of the questions in each section.
Scores range from 0 - 60. Lower scores = more disability, higher scores = less disability.
|
Post-Operative 6 months
|
Western Ontario and McMaster University Osteoarthritis Index (WOMAC)
Time Frame: Baseline Assessment
|
The WOMAC will be used as a self-administered health status measure in assessing pain, stiffness, and function in patients with OA of the hip or knee.
Higher scores on the WOMAC indicate worse pain, stiffness, and functional limitations.
|
Baseline Assessment
|
Western Ontario and McMaster University Osteoarthritis Index (WOMAC)
Time Frame: Pre-Operative Assessment
|
The WOMAC will be used as a self-administered health status measure in assessing pain, stiffness, and function in patients with OA of the hip or knee.
Higher scores on the WOMAC indicate worse pain, stiffness, and functional limitations.
|
Pre-Operative Assessment
|
Western Ontario and McMaster University Osteoarthritis Index (WOMAC)
Time Frame: Post-Operative 6 weeks
|
The WOMAC will be used as a self-administered health status measure in assessing pain, stiffness, and function in patients with OA of the hip or knee.
Higher scores on the WOMAC indicate worse pain, stiffness, and functional limitations.
With a scale ranges from 0 to 96.
Lower scores = more disability, higher scores = less disability.
|
Post-Operative 6 weeks
|
Western Ontario and McMaster University Osteoarthritis Index (WOMAC)
Time Frame: Post-Operative 6 months
|
The WOMAC will be used as a self-administered health status measure in assessing pain, stiffness, and function in patients with OA of the hip or knee.
Higher scores on the WOMAC indicate worse pain, stiffness, and functional limitations.
With a scale ranges from 0 to 96.
Lower scores = more disability, higher scores = less disability.
|
Post-Operative 6 months
|
IPAQ
Time Frame: Baseline Assessment
|
The 36-Item Short Form Health Survey (SF-12) will be used to measure health-related physical activity (PA) performance.
With a scale ranges from 0 to 96.
Lower scores = more disability, higher scores = less disability.
|
Baseline Assessment
|
IPAQ
Time Frame: Pre-Operative Assessment
|
The 36-Item Short Form Health Survey (SF-12) will be used to measure health-related physical activity (PA) performance.
Score is expressed as MET-min per week: MET level x minutes of activity x events per week.
Computed to fall into the category of: "Low", "Moderate" and "High" level of Physical Activity.
|
Pre-Operative Assessment
|
IPAQ
Time Frame: Post-Operative 6 weeks
|
The 36-Item Short Form Health Survey (SF-12) will be used to measure health-related physical activity (PA) performance.
Score is expressed as MET-min per week: MET level x minutes of activity x events per week.
Computed to fall into the category of: "Low", "Moderate" and "High" level of Physical Activity.
|
Post-Operative 6 weeks
|
IPAQ
Time Frame: Post-Operative 6 months
|
The 36-Item Short Form Health Survey (SF-12) will be used to measure health-related physical activity (PA) performance.
Score is expressed as MET-min per week: MET level x minutes of activity x events per week.
Computed to fall into the category of: "Low", "Moderate" and "High" level of Physical Activity.
|
Post-Operative 6 months
|
Hand-grip Strength
Time Frame: Baseline Assessment
|
Average of 3 times hand-grip strength values measures by a hand dynamometer grip strength meter.
|
Baseline Assessment
|
Hand-grip Strength
Time Frame: Pre-Operative Assessment
|
Average of 3 times hand-grip strength values measures by a hand dynamometer grip strength meter.
|
Pre-Operative Assessment
|
Hand-grip Strength
Time Frame: Post-Operative 6 weeks
|
Average of 3 times hand-grip strength values measures by a hand dynamometer grip strength meter.
|
Post-Operative 6 weeks
|
Hand-grip Strength
Time Frame: Post-Operative 6 months
|
Average of 3 times hand-grip strength values measures by a hand dynamometer grip strength meter.
|
Post-Operative 6 months
|
Gait Speed
Time Frame: Baseline Assessment
|
6 meter timed walking gait test
|
Baseline Assessment
|
Gait Speed
Time Frame: Pre-Operative Assessment
|
6 meter timed walking gait test
|
Pre-Operative Assessment
|
Gait Speed
Time Frame: Post-Operative 6 weeks
|
6 meter timed walking gait test
|
Post-Operative 6 weeks
|
Gait Speed
Time Frame: Post-Operative 6 months
|
6 meter timed walking gait test
|
Post-Operative 6 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CUHK_2018.403
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Knee Osteoarthritis
-
LifeBridge HealthMicroPort Orthopedics Inc.; Rubin Institute for Advanced OrthopedicsRecruitingKnee Osteoarthritis | Osteoarthritis, Knee | Knee Pain Chronic | Arthropathy of Knee Joint | Knee Disease | Osteoarthritis Knees Both | Osteoarthritis Knee Left | Osteoarthritis Knee RightUnited States
-
University Hospital, Clermont-FerrandSanofiCompletedKnee Osteoarthritis (Knee OA)France
-
Joseph E. BroylesCompletedDegenerative Lesion of Articular Cartilage of Knee | Degeneration; Articular Cartilage, Knee | Unilateral Primary Osteoarthritis of Knee | Osteoarthritis Knee
-
The Hong Kong Polytechnic UniversityCompleted
-
Federal University of São PauloCompletedKNEE OSTEOARTHRITISBrazil
-
Jiangsu XinChen-Techfields Pharma Co., LTD.Completed
-
Thammasat UniversityCompletedPrimary Knee OsteoarthritisThailand
-
Galderma R&DCompletedUnilateral Knee OsteoarthritisUnited Kingdom
-
National Yang Ming UniversityFar Eastern Memorial HospitalCompletedMedial Knee OsteoarthritisTaiwan
-
Hanlim Pharm. Co., Ltd.CompletedKnee OsteoarthritisKorea, Republic of
Clinical Trials on Vibration Therapy
-
Medical University of South CarolinaNational Institute of General Medical Sciences (NIGMS)Completed
-
Georgia State UniversityTerminatedFalls PreventionUnited States
-
University of ValenciaCompletedNeck Pain | Myofascial Trigger Point PainSpain
-
The Hong Kong Polytechnic UniversityCompleted
-
Indiana UniversityIndiana Clinical and Translational Sciences InstituteRecruitingCancer | Neuropathy | Chemotherapeutic Toxicity | Chemotherapeutic Drug - Induced NephropathyUnited States
-
SynDermix AGISS AGWithdrawnChronic Rhinosinusitis Without Nasal PolypsGermany, Austria, Switzerland
-
Logan College of ChiropracticUnknownSpinal Cord InjuryUnited States
-
The Hong Kong Polytechnic UniversityUnknown
-
Riphah International UniversityCompletedMechanical Low Back PainPakistan
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityCompletedHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm | Chemotherapy-Induced Peripheral NeuropathyUnited States